| Mrs Roxanne G Bybee, APRN | |
|
6 Steptoe Cir, Ely, NV 89301-2692 | |
| (775) 289-3001 | |
| Not Available |
| Full Name | Mrs Roxanne G Bybee |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 8 Years |
| Location | 6 Steptoe Cir, Ely, Nevada |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245776657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SF0001X | Clinical Nurse Specialist - Family Health | APRN002419 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| William Bee Ririe Hospital | Ely, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| William Bee Ririe Hospital | 9335051747 | 34 |
News Archive
Professionals whose jobs require more speaking, developing strategies, conflict resolution and managerial tasks may experience better protection against memory and thinking decline in old age than their co-workers, according to a new study published in the April 29, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma - a highly agressive tumor type that notoriously outsmarts current anti-cancer therapies.
How do physicians decide which colleague to refer their patient to? It differs depending on whether you ask primary care or specialist physicians, according to research from Harvard Medical School, Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center in Boston, USA, led by Michael Barnett.
› Verified 1 days ago
| Entity Name | William Bee Ririe Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487648804 PECOS PAC ID: 9335051747 Enrollment ID: O20031104000372 |
News Archive
Professionals whose jobs require more speaking, developing strategies, conflict resolution and managerial tasks may experience better protection against memory and thinking decline in old age than their co-workers, according to a new study published in the April 29, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma - a highly agressive tumor type that notoriously outsmarts current anti-cancer therapies.
How do physicians decide which colleague to refer their patient to? It differs depending on whether you ask primary care or specialist physicians, according to research from Harvard Medical School, Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center in Boston, USA, led by Michael Barnett.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Roxanne G Bybee, APRN Po Box 212, Lund, NV 89317-0212 Ph: () - | Mrs Roxanne G Bybee, APRN 6 Steptoe Cir, Ely, NV 89301-2692 Ph: (775) 289-3001 |
News Archive
Professionals whose jobs require more speaking, developing strategies, conflict resolution and managerial tasks may experience better protection against memory and thinking decline in old age than their co-workers, according to a new study published in the April 29, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
Endo Pharmaceuticals Inc., a subsidiary of Endo International plc, and BioDelivery Sciences International, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved BELBUCA (buprenorphine) buccal film for use in patients with chronic pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Research led by the Vall d'Hebron Institute of Oncology (VHIO) evidence the most conclusive preclinical results to-date validating Myc inhibition as a therapeutic strategy in glioma - a highly agressive tumor type that notoriously outsmarts current anti-cancer therapies.
How do physicians decide which colleague to refer their patient to? It differs depending on whether you ask primary care or specialist physicians, according to research from Harvard Medical School, Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center in Boston, USA, led by Michael Barnett.
› Verified 1 days ago